cropper
update
Hot Flash Pro
update
  • Home
  • Categories
    • Perimenopause Symptoms
    • Hormone Health & HRT
    • Lifestyle & Wellness
    • Midlife Productivity & Mental Health
    • Product Reviews & Tools for Relief
    • Nutrition for Hormonal Balance
    • Fitness & Movement in Midlife
    • Sleep & Recovery
    • Personal Stories & Experiences
    • Alternative & Holistic Therapies
    • Menopause at Work & Career Transitions
    • Emotional Wellbeing & Mindfulness
    • Expert Q&As & Interviews
    • Skin
    • Hair & Body Changes
March 12.2026
2 Minutes Read

Fezolinetant: New Hope for Women Facing Menopausal Symptoms

NICE supports NHS prescribing of fezolinetant

Fezolinetant Now Available in the NHS: A Game-Changer for Women

Recently, a significant development in women's health has occurred with the National Institute for Health and Care Excellence (NICE) endorsing the use of fezolinetant, also known as Veoza, on the NHS. This innovative medication provides a much-needed treatment for the hot flushes and night sweats associated with menopause, impacting the lives of nearly 500,000 women across England who can’t or prefer not to use hormone replacement therapy (HRT).

Understanding the Impact of Menopause Symptoms

Menopausal symptoms, particularly hot flushes and night sweats, can disrupt various aspects of a woman's daily life, including sleep, work performance, and relationships. These symptoms affect approximately 70% of women during menopause, showcasing a pressing healthcare need for effective management options. Traditionally, while HRT has been the main treatment option, its suitability does not extend to all women, such as those with specific health concerns or preferences against hormone therapy.

Fezolinetant: A Non-Hormonal Alternative

Fezolinetant is a non-hormonal solution in pill form, taken once daily. It works by blocking nerve pathways in the brain that trigger vasomotor symptoms, offering relief where HRT isn't viable. Dr. Sue Mann, NHS Clinical Director in Women’s Health, emphasized that this treatment option is vital for women who wish to manage their menopause symptoms effectively and take control of their health.

A Step Towards Empowering Women in Menopause

%The introduction of fezolinetant symbolizes a broader shift in recognizing and addressing the challenges women face during menopause. With options finally expanding to include non-hormonal treatments, women can partake in shared decision-making regarding their health care. Fezolinetant's approval is not just about alleviating symptoms, but also about restoring agency in women’s health care.

Get Involved and Explore More

If you or someone you know is navigating the perimenopause or menopause journey, it’s essential to stay informed about available treatment options. Understanding your choices can lead to a better quality of life during this transformative stage. Don't hesitate to consult with healthcare professionals about fezolinetant and other alternatives tailored to your specific needs!

Hormone Health & HRT

0 Comments

Write A Comment

*
*
Please complete the captcha to submit your comment.
Related Posts All Posts
04.28.2026

Dyslipidaemia in Menopause: Key Insights for Women’s Heart Health

Update Understanding Dyslipidaemia: A Key Concern in Menopause As women enter the peri-menopause and menopause stages, significant hormonal changes lead to an unsettling impact on lipid metabolism, making understanding dyslipidaemia critical for health. Research indicates a notable increase in total cholesterol levels by 30-50%, particularly due to decreased estrogen production. This post-menopausal period triggers a shift towards atherogenic lipid profiles, elevating the risk of cardiovascular diseases and shifting how fats are stored and mobilized. Notably, low-density lipoprotein (LDL), known as 'bad cholesterol', increases, while high-density lipoprotein (HDL), or 'good cholesterol', decreases. This can pose greater health risks compared to their male counterparts, especially for women with a family history of heart disease. The Role of Lifestyle Changes in Managing Symptoms Women experiencing menopausal symptoms and accompanying dyslipidaemia should prioritize lifestyle interventions over quick fixes. A balanced diet rich in fruits, vegetables, whole grains, and healthy fats can substantially lower cholesterol levels. Additionally, achieving a healthy weight through regular moderate exercise can help in managing both lipid levels and overall cardiovascular health. Studies suggest that making simple changes in diet and exercise routines greatly impact heart health, especially as women traverse through this transition. Debunking Common Misconceptions Around Menopause and Cardiovascular Health A prevalent myth is that menopause affects only reproductive health. In reality, the hormonal shifts occurring during this time significantly influence cardiovascular health. The link between menopause and cardiovascular diseases is often underappreciated, leading to lack of awareness among women about the importance of cardiovascular health, especially when they enter menopause. Education on this connection is crucial for early detection and management of cardiovascular risks. Conclusion: Empowering Women with Knowledge The journey through menopause can be daunting, especially as it intertwines with significant health risks like dyslipidaemia and cardiovascular disease. It’s crucial for women to be educated and understand the health changes they face during this transition. A proactive approach involving regular health check-ups and lifestyle changes can pave the way for healthier post-menopausal lives. Understanding these dynamics is empowering and essential not only for individual well-being but also for transforming the healthcare conversation surrounding women's health.

04.21.2026

Navigating Dyslipidemia During Menopause: Essential Insights for Women

Update Understanding Dyslipidemia in Menopause Dyslipidemia is a term that refers to abnormal levels of cholesterol and fats in the blood, which can significantly impact cardiovascular health. For women, navigating the menopausal transition introduces unique challenges. Menopause not only marks the end of menstrual cycles but also correlates with increasing levels of total cholesterol and low-density lipoprotein (LDL), often resulting in a lipid profile that poses a higher risk for heart disease. How Menopause Alters Cholesterol Levels As estrogen levels decline during menopause, women experience significant changes in their lipid profiles. Studies indicate that postmenopausal women typically see an increase in total cholesterol levels, specifically LDL, while high-density lipoprotein (HDL) levels decrease. This shift is crucial, given that men have always been perceived as more vulnerable to cardiovascular diseases. In reality, heart disease is a leading cause of death for women post-menopause, with recent research highlighting that many women may be unaware of their increased risk. The Importance of Proactive Cholesterol Management It’s essential for women in menopause to monitor their cholesterol levels and understand the implications of dyslipidemia on their health. Based on insights from studies published in the USC Journal and other health reports, managing cholesterol, which includes lifestyle changes like improved diet and regular physical activity, could mitigate the risk of developing cardiovascular diseases. For instance, integrating plant sterols and stanols into one’s diet can effectively lower LDL cholesterol, while the incorporation of omega-3 fatty acids and fiber can also mark positive changes. Empowering Women: Action Steps Women navigating perimenopause and early menopause should feel empowered to discuss these changes with their healthcare providers. Regular check-ups that include cholesterol screenings, paired with an emphasis on healthy eating and consistent physical activity, will play an essential role in reducing cardiovascular risks. Health practitioners should promote healthy weight management through nutrition and exercise, aiming for at least 150 minutes of moderate aerobic activity each week. What Lies Ahead for Women’s Health? The long-term health of women must be prioritized, particularly regarding cardiovascular risks post-menopause. While hormonal fluctuations and various lifestyle factors contribute to dyslipidemia, continual engagement with healthcare can open pathways to effective management strategies tailored to women’s unique experiences during this transitional period. Awareness and education about these changes can ultimately drive better health outcomes and encourage healthier lives. If you are in the perimenopause or menopause stages, consider scheduling an appointment with your healthcare provider to discuss your lipid profiles, weight management strategies, and overall cardiovascular health plans.

04.17.2026

Unlocking Aging Insights: How a 'Death' Protein Can Strengthen Your Immune System

Update Unraveling the Aging Puzzle: The MLKL Protein's Dual Role A groundbreaking discovery has unveiled the dual role of a protein, known as MLKL, which traditionally has been associated with cell death but now emerges as a critical player in the aging of blood stem cells. This revelation, stemming from research carried out at The University of Tokyo and St. Jude Children's Research Hospital, suggests that MLKL doesn’t just promote cell death; it may actually be spinning a web of complexities around how stem cells age and function. Why This Matters for Women in Perimenopause For women navigating perimenopause and early menopause, this research could carry profound implications. As the body undergoes hormonal changes, the immune system often experiences a decline in efficiency. Understanding the mechanisms behind stem cell aging is essential, as healthier stem cells can bolster the immune response, potentially alleviating issues like increased susceptibility to infections that many women encounter during this phase of life. How MLKL Impacts Mitochondrial Function In studies involving mice, it was found that when MLKL is activated, it tends to localize within the mitochondria of stem cells, damaging them and impairing energy production. This damage doesn’t lead to immediate cell death but instead compromises the cells' ability to regenerate and produce various blood components. This finding is crucial, as it underscores a new target for therapeutic intervention, especially in older adults who may be facing similar challenges. Implications for Future Therapies The pressing question that arises is: can we alter MLKL's activated pathways? Preliminary findings suggest that temporarily blocking MLKL’s influence during stressful events—in this case, medical treatments such as chemotherapy—may promote the survival and efficacy of blood stem cells, potentially leading to better health outcomes post-treatment. This is particularly relevant for women who have undergone difficult health journeys, such as those in remission from cancers prevalent in this demographic. Final Thoughts: What Can We Do?  As we continue to unveil these intricate biological questions, it becomes crucial for women to prepare for potential therapies that could enhance their resilience against age-related immune decline. Awareness about the impact of biological mechanisms such as those involving MLKL in blood stem cells can empower women to engage in preventive health strategies that strengthen their immune systems, especially during the challenging transitional phases of menopause.

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*